Further hearing loss during osteoporosis treatment with etidronate.

Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Yaşil, S., Cömlekçi, A., Güneri, A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Group 1998
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360958/
https://ncbi.nlm.nih.gov/pubmed/9799894
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk